Wiltrom Co

Wiltrom Co Diluted EPS

The Diluted Earnings per Share of Wiltrom Co (6767.TWO) as of Nov 5, 2026 is -0.49 TWD. In the previous year, Diluted Earnings per Share was -1.25 TWD — a change of -61.05% (higher).

Diluted EPS

-0.49TWD

YoY

-61.05%

Last updated:

Diluted Earnings per Share of Wiltrom Co is 2025 -0.49 TWD. Diluted Earnings per Share of Wiltrom Co was 2024 -1.25 TWD. It decreases by -61.05% higher compared to the previous year.

The Wiltrom Co Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
-1.18 TWD
Jan 1, 2019
0.30 TWD
Jan 1, 2020
-0.51 TWD
Jan 1, 2021
-1.63 TWD
Jan 1, 2022
-0.58 TWD
Jan 1, 2023
0.05 TWD
Jan 1, 2024
-1.25 TWD
Jan 1, 2025
-0.49 TWD
The Wiltrom Co Diluted EPS history
YEARDiluted EPSYoY
-0.49TWD-61.05%
-1.25TWD-2,551.93%
0.05TWD-108.75%
-0.58TWD-64.17%
-1.63TWD+219.21%
-0.51TWD-270.00%
0.30TWD-125.42%
-1.18TWD+306.90%
-0.29TWD-1,550.00%
0.02TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wiltrom Co Stock analysis

What does Wiltrom Co do? Wiltrom Co., Ltd. generates revenue through the research, production, and distribution of high-end medical devices, including spinal fixators, artificial bones, and interbody fusion cages. The company focuses on Class II and Class III implantable devices, targeting spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. Its primary markets are Taiwan, Asia, and America, where it sells directly to hospitals and medical institutions. The firm's product portfolio is designed for specialized surgical procedures, with spinal fusion surgery products forming a core segment of its business. The company's revenue streams are derived from the sale of spinal fixators, artificial bones, and interbody fusion cages, which are categorized under spinal fusion surgery, spinal compression fracture surgery, and bone cement product segments. These products are distributed across Taiwan, Asia, and America, with a strong emphasis on the spinal fusion surgery market. Wiltrom's focus on high-end, implantable Class II and Class III medical devices ensures a premium pricing strategy, aligning with the specialized needs of surgical procedures. Wiltrom Co., Ltd. serves healthcare providers in Taiwan, Asia, and America, delivering Class II and Class III medical devices for spinal fusion, spinal compression fracture, and bone cement applications. The company's products are tailored to specific surgical segments, with spinal fusion surgery products representing a significant portion of its sales. Revenue is generated through direct sales to hospitals and medical institutions within its key geographic markets. Wiltrom Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wiltrom Co stock

Diluted Earnings per Share of Wiltrom Co is -0.49 TWD in 2025.

Diluted Earnings per Share of Wiltrom Co changed from -1.25 TWD to -0.49 TWD, representing a -61.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share Wiltrom Co since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Wiltrom Co

All Key Metrics — Wiltrom Co